Variables | Annual cost of operation | Sharing rate | # of HIV averted | # of HCV averted | Cost-effectiveness ratio HCV | Cost-effectiveness ratio HIV | Benefit-cost ratio HCV | Benefit-cost ratio HIV | Cost-benefit ratio Total |
---|---|---|---|---|---|---|---|---|---|
Post SIF | $2,182,800 | 11% | 5 | 48 | $45,475 | $436,560 | 0.77 | 0.48 | 1.26 |
 |  | (14%, 7%) | (6, 3) | (65, 31) | (33,581, $70,413) | ($363,800, $727,600) | (1.1, 0.5) | (0.58, 0.3) | (1.63, 0.79) |
Two SIF | $2,182,800 | 8% | 4 | 41 | $53,239 | $545,700 | 0.66 | 0.39 | 1.05 |
 |  | (11%, 5%) | (6, 3) | (55, 26) | ($39,687, $83,954) | ($363,800, $727,600) | (0.89, 0.42) | (0.58, 0.3) | (1.46, 0.71) |
Three SIF | $2,182,800 | 6% | 2 | 24 | $90,950 | $1,091,400 | 0.39 | 0.19 | 0.58 |
 |  | (9%, 4%) | (3, 1) | (28, 14) | ($77,957, $155,914) | ($727,600, $2,182,800) | (0.45, 0.23) | (0.29, 0.1) | (0.74, 0.32) |
Four SIF | $2,182,800 | 5% | 2 | 17 | $128,400 | $1,091,400 | 0.27 | 0.19 | 0.47 |
 |  | (7%, 3%) | (3, 1) | (28, 13) | ($77,957, $167,908) | ($727,600, $2,182,800) | (0.45, 0.21) | (0.29, 0.1) | (0.74, 0.31) |
Five SIF | $2,182,800 | 3% | 2 | 21 | $103,943 | $1,091,400 | 0.34 | 0.19 | 0.53 |
 |  | (5%, 2%) | (3, 1) | (28, 13) | ($77,957, $167,908) | ($727,600, $2,182,800) | (0.45, 0.21) | (0.29, 0.1) | (0.74, 0.31) |
Six SIF | $2,182,800 | 2% | 2 | 21 | $103,943 | $1,091,400 | 0.34 | 0.19 | 0.53 |
 |  | (3%, 1%) | (3, 1) | (28, 13) | ($77,957, $167,908) | ($727,600, $2,182,800) | (0.45, 0.21) | (0.29, 0.1) | (0.74, 0.31) |
Seven SIF | $2,182,800 | 1% | 2 | 21 | $103,943 | $1,091,400 | 0.34 | 0.19 | 0.53 |
 |  | (1%, 1%) | (3, 1) | (28, 13) | ($77,957, $167,908) | ($727,600, $2,182,800) | (0.45, 0.21) | (0.29, 0.1) | (0.74, 0.31) |